Furthermore, a comprehensive sequencing aiming to identify somatic mutations in potentially oncogenic kinases revealed ALPK2, as one of the mutated genes in human cancers such as ovarian cancer [18, 19]. The gene discussed is ALPK2; the disease is ovarian carcinoma.